Dube Michael P
Intellia Therapeutics, Inc. · VP
Dube Michael P is listed in public filings as officer: VP, Chief Accounting Officer. This Dube Michael P insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Intellia Therapeutics, Inc. (NTLA). Investors use Dube Michael P's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --69.5k shares | Grant / ExerciseMar 1, 2026 | Disclosure amount unavailable17.3k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $481k52.3k shares | SellJan 5, 2026 | $27.5K3k shares | $9.21 | -- | |
| $961k55.3k shares | SellOct 1, 2025 | $32.5K1.9k shares | $17.38 | -- | |
| $569k57.1k shares | SellJul 2, 2025 | $24.9K2.5k shares | $9.95 | -- | |
| --59.6k shares | Grant / ExerciseMar 1, 2025 | Disclosure amount unavailable14k shares | -- | -- | |
| $556k45.6k shares | SellJan 3, 2025 | $16.7K1.4k shares | $12.18 | -- | |
| $894k47k shares | SellOct 2, 2024 | $38.2K2k shares | $19.01 | -- | |
| --49k shares | Grant / ExerciseJul 1, 2024 | Disclosure amount unavailable17.8k shares | -- | -- |